Literature DB >> 2664471

Characterization of the human p53 gene promoter.

S P Tuck1, L Crawford.   

Abstract

Transcriptional deregulation of the p53 gene may play an important part in the genesis of some tumors. We report here an accurate determination of the transcriptional start sites of the human p53 gene and show that the majority of p53 mRNA molecules do not contain a postulated stem-loop structure at their 5' ends. Recombinant plasmids of the human p53 promoter-leader region fused to the bacterial chloramphenicol acetyltransferase gene (cat) were constructed. After transfection into rodent or human cells, a 350-base-pair fragment spanning the promoter region conferred 4% of the CAT activity mediated by the simian virus 40 early promoter/enhancer. We monitored the efficiency with which 15 3' and 5' promoter deletion constructs initiated transcription. Our results show that an 85-base-pair fragment, previously thought to have resided in exon 1, is all that is required for full promoter activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664471      PMCID: PMC363010          DOI: 10.1128/mcb.9.5.2163-2172.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity.

Authors:  S Schirm; J Jiricny; W Schaffner
Journal:  Genes Dev       Date:  1987-03       Impact factor: 11.361

2.  Rearrangement of the p53 gene in human osteogenic sarcomas.

Authors:  H Masuda; C Miller; H P Koeffler; H Battifora; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system.

Authors:  J M Heard; P Herbomel; M O Ott; A Mottura-Rollier; M Weiss; M Yaniv
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  Characterization of the human p53 gene.

Authors:  P Lamb; L Crawford
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

5.  Primary structure polymorphism at amino acid residue 72 of human p53.

Authors:  G J Matlashewski; S Tuck; D Pim; P Lamb; J Schneider; L V Crawford
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

6.  Changes in p53 mRNA expression during terminal differentiation of murine erythroleukemia cells.

Authors:  R Bendori; D Resnitzky; A Kimchi
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

7.  Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

Authors:  D I Linzer; A J Levine
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

8.  Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes.

Authors:  V Chow; Y Ben-David; A Bernstein; S Benchimol; M Mowat
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

9.  Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.

Authors:  M Oren; W Maltzman; A J Levine
Journal:  Mol Cell Biol       Date:  1981-02       Impact factor: 4.272

10.  Comparative analysis of the involvement of p53, c-myc and c-fos in epidermal growth factor-mediated signal transduction.

Authors:  J Filmus; S Benchimol; R N Buick
Journal:  Exp Cell Res       Date:  1987-04       Impact factor: 3.905

View more
  35 in total

1.  Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours.

Authors:  B K Nayak; B R Das
Journal:  Mol Biol Rep       Date:  1999-12       Impact factor: 2.316

Review 2.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

3.  Segmental genomic replacement by Cre-mediated recombination: genotoxic stress activation of the p53 promoter in single-copy transformants.

Authors:  B Bethke; B Sauer
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.

Authors:  D Ronen; V Rotter; D Reisman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

5.  The tumor suppressor p53 regulates its own transcription.

Authors:  A Deffie; H Wu; V Reinke; G Lozano
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.

Authors:  E E Furlong; T Rein; F Martin
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 7.  Response of tumour cells to hypoxia: role of p53 and NFkB.

Authors:  J A Royds; S K Dower; E E Qwarnstrom; C E Lewis
Journal:  Mol Pathol       Date:  1998-04

8.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system.

Authors:  N Tanaka; T Kawakami; T Taniguchi
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.